Log In
Print this Print this

hydrocodone bitartrate (Zohydro ER) (ZX002)

  Manage Alerts
Collapse Summary General Information
Company Pernix Therapeutics Holdings Inc.
DescriptionOral controlled-release formulation of hydrocodone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat moderate to severe chronic pain
Regulatory Designation U.S. - Undisclosed Review (Treat moderate to severe chronic pain)
PartnerAlkermes plc;
Endo International plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today